News & Updates
Filter by Specialty:
Newer fixed-dose ICS/LABA combos tied to greater adherence, less exacerbations in asthma
Among fixed-dose combinations of inhaled corticosteroids/long-acting beta-2-adrenergic agonists (ICS/LABA), the newer combinations of fluticasone furoate/vilanterol (FF/VI) and fluticasone propionate/formoterol (FP/FORM) are associated with increased treatment persistence and lead to fewer exacerbations among patients with asthma, as shown in a study.
Newer fixed-dose ICS/LABA combos tied to greater adherence, less exacerbations in asthma
05 May 2022
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
The eutectic-like mixture of prilocaine/lidocaine spray appears to work well in the treatment of men with various types of premature ejaculation, as reflected by a high treatment adherence, according to data from a real-world study.
Prilocaine/lidocaine spray safe, effective in men with premature ejaculation
05 May 2022
Statins confer some protection against breast cancer recurrence in Asians
Taking a statin after breast cancer surgery appears to reduce the risk of disease recurrence in Asians, especially among those with invasive cancers, as shown in a study from Singapore.
Statins confer some protection against breast cancer recurrence in Asians
04 May 2022
Nirmatrelvir-ritonavir cuts disease progression, viral load in unvaccinated COVID-19 outpatients
In the phase II/III EPIC-HR* trial, the novel oral antiviral nirmatrelvir-ritonavir reduced the risk of progression of COVID-19 to severe disease, as well as viral load, in symptomatic, high-risk, unvaccinated nonhospitalized adults confirmed to have SARS-CoV-2 infection.
